HEALTH CATALYST, INC. (HCAT) News
Filter HCAT News Items
HCAT News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
HCAT News Highlights
- For HCAT, its 30 day story count is now at 3.
- Over the past 5 days, the trend for HCAT's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
- DEC and PR are the most mentioned tickers in articles about HCAT.
Latest HCAT News From Around the Web
Below are the latest news stories about HEALTH CATALYST INC that investors may wish to consider to help them evaluate HCAT as an investment opportunity.
Why Are Health Catalyst (HCAT) Shares Soaring TodayShares of healthcare software provider Health Catalyst (NASDAQ:HCAT) jumped 6.5% in the morning session, reflecting the broader market's ongoing uptrend, which some may playfully call the Santa Claus rally (a real observed phenomenon where the market tends to drift upwards during the holiday season for reasons such as optimism and year-end tax considerations for funds and investors). All major indices rose, fueled by growing optimism about the Federal Reserve not only concluding its rate hikes b |
Health Catalyst to Participate in Upcoming Investor ConferenceSALT LAKE CITY, Dec. 14, 2023 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton, Chief Executive Officer, Bryan Hunt, Chief Financial Officer, and Adam Brown, Senior Vice President of FP&A and Investor Relations, will participate in the 42nd Annual J.P. Morgan Healthcare Conference, being held in San Francisco. In conjunction, there will be a pr |
Health Catalyst, Inc. (NASDAQ:HCAT) Shares Could Be 49% Below Their Intrinsic Value EstimateKey Insights Using the 2 Stage Free Cash Flow to Equity, Health Catalyst fair value estimate is US$16.28 Health... |
Health Catalyst's Analytics Solutions Save WakeMed Health & Hospitals $10 Million, Accelerates Clinical TransformationHealth Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, announced WakeMed Health & Hospitals ("WakeMed") has achieved $10M variable cost reduction by decreasing unnecessary care variation while helping to improve care quality. |
Health Catalyst to Participate in Upcoming Investor ConferencesSALT LAKE CITY, Nov. 24, 2023 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Bryan Hunt, Chief Financial Officer, and Adam Brown, Senior Vice President of FP&A and Investor Relations, will participate in the following upcoming investor conferences: Piper Sandler 35th Annual Healthcare Conference, being held in New York, on Wednesday, November 29, 2023, |
Health Catalyst (HCAT) Stock Trades Up, Here Is WhyShares of healthcare software provider Health Catalyst (NASDAQ:HCAT) jumped 5.7% in the morning session after Piper Sandler analyst Jessica Tassan upgraded the stock's rating from Neutral (Hold) to Overweight (Buy). Tassan expressed confidence in the company's tech-enabled managed services (TEMS) to bring in new customers and boost EBITDA growth, aligning with management's Q3'23 earnings call forecast that the largest part of Q4'23 bookings would come from TEMS. The analyst also commended Health |
Health Catalyst, Inc. (NASDAQ:HCAT) Q3 2023 Earnings Call TranscriptHealth Catalyst, Inc. (NASDAQ:HCAT) Q3 2023 Earnings Call Transcript November 3, 2023 Operator: Welcome to the Health Catalyst Third Quarter 2023 Earnings Conference Call. [Operator Instructions] I would now like to turn the call over to Adam Brown, Senior Vice President of FP&A and Investor Relations. Adam Brown: Good afternoon and welcome to Health Catalyst’s […] |
Health Catalyst Inc (HCAT) Reports 8% Revenue Growth in Q3 2023Adjusted EBITDA Reaches $2.0 Million, Beating Mid-Point Guidance |
Compared to Estimates, Health Catalyst (HCAT) Q3 Earnings: A Look at Key MetricsThe headline numbers for Health Catalyst (HCAT) give insight into how the company performed in the quarter ended September 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals. |
Health Catalyst Reports Third Quarter 2023 ResultsHealth Catalyst Q3 2023 Financial Highlights & Key Themes November 2, 2023 SALT LAKE CITY, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended September 30, 2023. “For the third quarter of 2023, I am pleased by our strong financial results, including total revenue of $73.8 million and Adjusted EBITDA of $2.0 mi |